{"id":618393,"date":"2023-03-15T17:49:39","date_gmt":"2023-03-15T22:49:39","guid":{"rendered":"https:\/\/news.sellorbuyhomefast.com\/index.php\/2023\/03\/15\/goldman-sachs-fund-manager-describes-outcome-health-investment\/"},"modified":"2023-03-15T17:49:39","modified_gmt":"2023-03-15T22:49:39","slug":"goldman-sachs-fund-manager-describes-outcome-health-investment","status":"publish","type":"post","link":"https:\/\/newsycanuse.com\/index.php\/2023\/03\/15\/goldman-sachs-fund-manager-describes-outcome-health-investment\/","title":{"rendered":"Goldman Sachs fund manager describes Outcome Health investment"},"content":{"rendered":"<div>\n<p><a href=\"http:\/\/www.modernhealthcare.com\/#main-content\" data-swiftype-index=\"false\"><br \/>\nSkip to main content<br \/>\n<\/a><\/p>\n<div data-off-canvas-main-canvas>\n<p><main role=\"main\"><br \/>\n<span id=\"main-content\" tabindex=\"-1\"><\/span><\/p>\n<div>\n<div itemscope itemtype=\"http:\/\/schema.org\/Article\">\n<div data-block-plugin-id=\"entity_field:node:field_emphasis_image\">\n<p><span itemscope itemtype=\"http:\/\/schema.org\/ImageObject\"><br \/>\n<a href=\"https:\/\/s3-prod.modernhealthcare.com\/s3fs-public\/Dirksen%20Federal%20Building.png\" data-lightbox=\"lightbox-main-wrapper\" data-title=\"%3Cdiv%20class%3D%22article-main-image-credit%22%3EGeneral%20Services%20Administration%3C%2Fdiv%3E%3Cdiv%20class%3D%22article-main-image-caption%22%3E%3Cp%3EThe%20Dirksen%20Federal%20Building%20in%20Chicago%3C%2Fp%3E%3C%2Fdiv%3E\">\n<picture><source  media=\"all and (min-width: 1024px)\" type=\"image\/png\"><source  media=\"all and (min-width: 768px)\" type=\"image\/png\"><source  type=\"image\/png\"><img decoding=\"async\" original=\"https:\/\/s3-prod.modernhealthcare.com\/s3fs-public\/Dirksen%20Federal%20Building.png\" src=\"https:\/\/s3-prod.modernhealthcare.com\/s3fs-public\/styles\/width_792\/public\/Dirksen%20Federal%20Building.png\" alt=\"Dirksen Federal Building.png\" typeof=\"foaf:Image\">\n<\/picture>\n<\/a><br \/>\n<\/span>\n<\/p>\n<div>\n<p>\nGeneral Services Administration\n<\/p>\n<p>The Dirksen Federal Building in Chicago<\/p>\n<\/div>\n<\/div>\n<div data-block-plugin-id=\"entity_field:node:field_paragraphs\">\n<div itemprop=\"articleBody\">\n<html><body><\/p>\n<p>A Goldman Sachs fund manager knew there was going to be trouble when he read a Wall Street Journal story that accused Outcome Health of overbilling drug companies and misleading them about the effectiveness of their advertising on prescription sales.<\/p>\n<p>&#8220;I recall reading that reports (to customers) were being altered, mentioning a drug that was in our diligence packet,&#8221; Ken Eberts, former co-head of Goldman Sachs Investment Partners, testified Monday during the federal fraud trial of Outcome Health founders Rishi Shah, Shradha Agarwal and Brad Purdy, the company&#8217;s former chief financial officer. &#8220;To us it was very concerning that something was going wrong.&#8221;<\/p>\n<p><a href=\"https:\/\/www.modernhealthcare.com\/legal\/outcome-health-trial-lawyer-whistleblower-worries-collin-williams\" data-omnilocation=\"articlebody\" data-omnilink=\"editorial-link\"><em>Related:\u00a0Outcome Health ex-lawyer details breaking point to jury<\/em><\/a><\/p>\n<p><\/body><br \/>\n<\/html><\/div>\n<div itemprop=\"articleBody\">\n<html><body><\/p>\n<p>The fund overseen by Eberts had made a $100 million investment just months earlier, in March 2017, as part of what ended up being a $488 million deal that dramatically raised the profile of the Chicago-based company and its founders.<\/p>\n<p>Eberts, who later retired from Goldman Sachs after 30 years, described why the firm <a href=\"https:\/\/www.modernhealthcare.com\/legal\/outcome-health-fraud-trial-debt-accent-health-rishi-shah-ashik-desai-brad-purdy\" data-omnilocation=\"articlebody\" data-omnilink=\"editorial-link\">invested in Outcome Health<\/a> and agreed to let Shah and Agarwal take $225 million off the table.\u00a0He said the company \u2014 which operated a network of\u00a0TV screens and tablet computers mostly in specialist doctors&#8217; offices \u2014 was profitable and growing fast.<\/p>\n<p>Outcome Health&#8217;s revenue had roughly doubled the previous year, and the company was predicting sales would triple to $450 million in 2017, following an acquisition, according to a pitch deck shown in court. The company&#8217;s operating profit \u2014 or earnings before interest, taxes and depreciation \u2014 was nearly 50%.<\/p>\n<p>Also attractive to investors was the company&#8217;s claim that its advertising platform, which targeted patients as they were in doctor&#8217;s offices for treatment, produced an increase in drug company sales that was twice as high as traditional TV and print ads.<\/p>\n<p><a href=\"https:\/\/www.modernhealthcare.com\/subscribe\" data-omnilocation=\"articlebody\" data-omnilink=\"editorial-link\"><em>Not a Modern Healthcare subscriber? Sign up today.<\/em><\/a><\/p>\n<p>Prosecutors claim that the company overbilled its clients for advertising it did not deliver, which inflated the company&#8217;s financial results by up to 25%. Investors who relied on those results were defrauded, the government contends. Shah, Agarwal and Purdy have denied the charges.<\/p>\n<p>The investment deal had an unusual structure. Goldman and others would invest $100 million in a holding company that would go public within four years. When the IPO happened, their investment would convert to shares at a rate that included a 20% increase for each year. If Outcome had gone public after a year, Goldman&#8217;s stake would have translated into $120 million worth of shares at the IPO. Goldman had used a similar structure in an investment in Uber, Eberts said.<\/p>\n<p>&#8220;The structure of our security was effectively providing a 20% return while buying stock in a future IPO, with what we hoped to be a reasonable margin of safety,&#8221; he said.<\/p>\n<p>Goldman was the largest investor in a $350 million deal that involved other venture and private-equity funds. The total fundraiser ultimately grew to $488 million.\u00a0The $225 million payout to Shah and Agarwal raised questions for the investment committee.<\/p>\n<p>&#8220;We believed the company was worth $2.5 billion or more. In that context, the distribution to the founders would have been a little less than 10%,&#8221; Eberts said. &#8220;Although it was a large amount of money, it wasn&#8217;t a large proportion of their wealth.&#8221;<\/p>\n<p>Goldman and other investors, including Google&#8217;s Capital G and the Chicago venture-capital fund formerly headed by Gov. J.B. Pritzker, ultimately<a href=\"https:\/\/www.chicagobusiness.com\/article\/20171108\/BLOGS11\/171109880\/outcome-health-investors-in-open-war-over-225-million\" target=\"_blank\" data-omnilocation=\"articlebody\" data-omnilink=\"editorial-link\" rel=\"noopener\">\u00a0sued Shah and Agarwal<\/a> to recover some of the money they had received as part of investment after the fraud allegations surfaced.<\/p>\n<p>Coming just months after the deal, those fraud allegations also raised questions over the diligence by Goldman and other investors. Shah&#8217;s attorney, John Hueston, raised those questions as he began cross examination Monday. He pointed to an email from a member of the investment committee for the Goldman fund, noting that one of the return-on-investment examples seemed small. &#8220;I assume we will be looking for many more in diligence?&#8221;<\/p>\n<p><a href=\"https:\/\/www.chicagobusiness.com\/technology\/outcome-health-trial-goldman-sachs-investor-testifies\" data-omnilocation=\"articlebody\" data-omnilink=\"editorial-link\"><em>This story first appeared in Crain&#8217;s Chicago\u00a0Business.<\/em><\/a><\/p>\n<p><\/body><br \/>\n<\/html><\/div>\n<\/div>\n<\/div>\n<\/div>\n<p><\/main><\/p>\n<\/div>\n<\/div>\n<p><a href=\"https:\/\/www.modernhealthcare.com\/legal\/outcome-health-fraud-trial-goldman-sachs-investment-overbilling\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><br \/>\n Crain&#039;s Chicago Business<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Skip to main content General Services Administration The Dirksen Federal Building in Chicago A Goldman Sachs fund manager knew there was going to be trouble when he read a Wall Street Journal story that accused Outcome Health of overbilling drug companies and misleading them about the effectiveness of their advertising on prescription sales. &#8220;I recall<\/p>\n","protected":false},"author":1,"featured_media":618394,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[97,98],"tags":[],"class_list":{"0":"post-618393","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-goldman","8":"category-sachs"},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/618393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/comments?post=618393"}],"version-history":[{"count":0,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/618393\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media\/618394"}],"wp:attachment":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media?parent=618393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/categories?post=618393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/tags?post=618393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}